Loading...

Home
ETF
ABVC

ABVC

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ABVC News

Plus Therapeutics Prices Public Offering, Raising $15 Million

Jan 15 2026NASDAQ.COM

ABVC BioPharma, Inc. (ABVC) Sees 103% Increase in Assets, Preparing for Phase III Trials of Depression Treatments

Sep 23 2025Yahoo Finance

Abvc BioPharma Doubles Assets in Q2

Aug 14 2025NASDAQ.COM

ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21

Dec 19 2024Newsfilter

ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners

Dec 11 2024Newsfilter

ABVC BioPharma gets $200K in cash from OncoX BioPharma

Dec 11 2024SeekingAlpha

ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones

Nov 14 2024Newsfilter

ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners

Oct 22 2024Newsfilter

ABVC Stock Earnings: ABVC BioPharma Reported Results for Q2 2024

Aug 15 2024Business Insider

ABVC Biopharma files to sell 1M shares of common stock for holders

Jun 21 2024SeekingAlpha

ABVC Stock Earnings: ABVC BioPharma Reported Results for Q1 2024

May 18 2024Business Insider

PHG, IBRX and MESO are among premarket gainers

Apr 29 2024SeekingAlpha

Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Apr 24 2024Benzinga

BACK, ZPTA and ABVC are among premarket gainers

Apr 24 2024SeekingAlpha

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

Apr 18 2024newsfilter

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

Apr 17 2024newsfilter